(PC) Jones v. Bick

CourtDistrict Court, E.D. California
DecidedFebruary 22, 2024
Docket2:21-cv-01603
StatusUnknown

This text of (PC) Jones v. Bick ((PC) Jones v. Bick) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
(PC) Jones v. Bick, (E.D. Cal. 2024).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 FOR THE EASTERN DISTRICT OF CALIFORNIA 10 11 DESMOND JONES, No. 2:21-cv-01603-TLN-EFB (PC) 12 Plaintiff, 13 v. FINDINGS AND RECOMMENDATIONS 14 CAMPBELL, et al., 15 Defendants. 16 17 Plaintiff is a state prisoner proceeding without counsel in an action brought under 42 18 U.S.C. § 1983. ECF No. 1. On April 29, 2022, pursuant to 28 U.S.C. § 1915A(a), the court 19 determined that plaintiff’s third amended complaint (TAC) (ECF. No. 17) alleged potentially 20 cognizable Eighth Amendment claims for deliberate indifference to medical needs against 21 defendants Tyler Campbell and La Don Silva. ECF No. 19. Defendants now move for summary 22 judgment. For the following reasons, the motion for summary judgment should be granted. 23 I. The Complaint 24 The TAC alleges that in August of 2020, plaintiff’s primary care provider, defendant Dr. 25 Tyler Campbell at the California Men’s Colony (CMC), and defendant LaDon Silva, a registered 26 dietician nurse at the California Department of Corrections and Rehabilitation (CDCR) 27 headquarters in Sacramento, discontinued plaintiff’s order of Ensure, knowing that plaintiff drank 28 it to control the effects of moderate to severe malnutrition caused by hyperthyroidism. Plaintiff 1 also alleges that defendants knew that plaintiff needed Ensure, which has immune boosting 2 properties, because of plaintiff’s compromised immune system caused by the medication 3 methimazole. On December 21, 2020, plaintiff became infected with Covid-19 and remained 4 symptomatic through January 11, 2021. He alleges that by February of 2021, he had dropped 5 from 155 pounds to 138 pounds. He further asserts that when he complained to Campbell, 6 Campbell denied responsibility, claiming that Silva had declined to order more Ensure for 7 plaintiff. ECF No. 17 at 6. Plaintiff alleges that Silva did not order more Ensure for plaintiff 8 until August of 2021, at which point plaintiff had lost twenty pounds. Id. at 10. 9 II. The Parties’ Factual Contentions and Evidence 10 Defendants maintain that when plaintiff arrived at CMC in August 2015, he had recently 11 been diagnosed with hyperthyroidism, which results in the thyroid making and releasing high 12 levels of thyroid hormone. Plaintiff’s Depo. (ECF No. 38) at 14-16, 21; Campbell Decl. (ECF 13 No. 37-5) at ¶ 4. Hyperthyroidism can result in weight loss, in addition to other side effects. 14 Campbell Decl. (ECF No. 37-5) at ¶ 5. Methimazole, which can reduce the amount of thyroid 15 hormone in the body, is one medication used to treat hyperthyroidism. Id. at ¶ 6. While on 16 methimazole, a patient may develop a condition called agranulocytosis which elevates the risk of 17 infection; this side effect, however, is reportedly rare, at between 0.1-0.5% of patients. Id. at ¶¶ 18 7-9. 19 Defendant Campbell was plaintiff’s primary care physician during his entire incarceration 20 at CMC, beginning in 2015. Plaintiff’s Depo. (ECF No. 38) at 22-23; 37; Campbell Decl. (ECF 21 No. 37-5) at ¶ 4. Plaintiff testified that he thought defendant Campbell was looking out for his 22 best interest. Plaintiff’s Depo. (ECF No. 38) at 37. Defendant Campbell prescribed methimazole 23 to plaintiff, referred him to an endocrinologist, and monitored plaintiff’s white blood cell count 24 for agranulocytosis. Campbell Decl. (ECF No. 37-5) at ¶¶ 10-21. By April 2020, plaintiff’s 25 thyroid hormone levels were within the normal range. Campbell Decl. (ECF No. 37-5) at ¶ 19. 26 In addition to prescribing methimazole, defendant Campbell initially prescribed Ensure 27 (which contains 250 calories per can) to plaintiff. Plaintiff received six cans daily. Campbell 28 Decl. (ECF No. 37-5) at ¶ 17; Silva Decl. (ECF No. 37-6) at ¶¶ 11-13. In August 2020, 1 defendant Silva received an order to renew plaintiff’s order for Ensure. Silva Decl. (ECF No. 37- 2 6) at ¶ 13. Based on the applicable procedures, defendant Silva calculated plaintiff’s BMI and 3 determined that, because it was within the normal range, plaintiff did not require extra calories 4 from Ensure. Id. at ¶¶ 13-14; see also Ex. 3 (plaintiff’s progress notes) to Campbell Decl. (ECF 5 No. 37-5). Plaintiff’s medical records indicate that the Chief Physician and Surgeon agreed with 6 the recommendation to discontinue the order for Ensure, as did defendant Campbell. Plaintiff’s 7 order for Ensure was discontinued on August 21, 2020. Id. 8 Plaintiff was subsequently seen by an endocrinologist in November 2020; while plaintiff 9 had lost some weight, his BMI remained within the normal range. Campbell Decl. (ECF No. 37- 10 5) at ¶¶ 25, 31-32 and Exs. 5 and 7. While the endocrinologist indicated that plaintiff could 11 restart Ensure, defendant Campbell rejected this recommendation because plaintiff’s BMI was in 12 the normal range, and a dietician calculated that the CDCR diet was meeting plaintiff’s nutritional 13 and caloric needs. Id. at ¶¶ 25, 31-32 and Exs. 5 and 7. 14 In December 2020, plaintiff tested positive for Covid-19. Plaintiff’s Depo. (ECF No. 38) 15 at 52; Campbell Decl. (ECF No. 37-5) at ¶ 27. Plaintiff was placed in isolation and his vital signs 16 were monitored by the nursing staff. Plaintiff’s Depo. (ECF No. 38) at 52-56; Campbell Decl. 17 (ECF No. 37-5) at ¶ 27 and Ex. 6. Plaintiff’s vital signs remained normal, and no symptoms of 18 Covid-19 were recorded. Id. Plaintiff was released from isolation on January 11, 2021. 19 Campbell Decl. (ECF No. 37-5) at ¶ 27 and Ex. 6. There was no indication that plaintiff had 20 agranulocytosis. Id. 21 When plaintiff met with defendant Campbell in February 2021, he weighed less than he 22 had at his November 2020 endocrinology visit. Campbell Decl. (ECF No. 37-5) at ¶¶ 25, 30-32 23 and Ex. 7. His BMI remained in the normal range, however, and defendant Campbell determined 24 that Ensure was still not indicated for plaintiff. Id. Defendant Campbell did order blood work for 25 plaintiff. Id. 26 Plaintiff then submitted a healthcare appeal, requesting that he be provided with Ensure. 27 Silva Decl. (ECF No. 37-6) at ¶ 15. Defendant Silva reviewed plaintiff’s medical records, and 28 determined that plaintiff’s BMI remained in the normal range, and that the CDCR diet provided 1 him with adequate calories. Id. at ¶¶ 15-17 and Ex. 6. Defendant Silva thus declined to reinstate 2 plaintiff’s Ensure order. Id. at ¶¶ 15-18 and Ex. 12. Plaintiff’s thyroid-related hormone levels 3 were “at goal” at this time, and his BMI remained within the normal range. Campbell Decl. (ECF 4 No. 37-5) at ¶ 33-34 and Exs. 8-9. 5 In August 2021, plaintiff’s Ensure order was reinstated. Id. at ¶ 36 & Ex. 11. While 6 plaintiff’s BMI remained in the normal range, it had fallen slightly below 20 and was no longer in 7 the ideal range. Id. Plaintiff’s BMI then rose to about 20 and remained there until defendant 8 Campbell’s last visit with plaintiff in February 2022. Id. at ¶ 37. Plaintiff was released from 9 custody in April 2022 and his weight has remained stable. Plaintiff’s Depo. (ECF No. 38) at 19, 10 70. He sees a doctor for his hyperthyroidism about twice a year, and his dosage of methimazole 11 is the same. Id. Defendants maintain that, because plaintiff’s weight remained in the normal 12 range and he did not develop agranulocytosis, plaintiff did not suffer any physical injury that 13 would entitle him to relief. 14 Plaintiff has submitted a separate statement of disputed material facts.1 ECF No. 44-1. 15 Plaintiff’s primary areas of disputes are as follows. Plaintiff contends that his weight loss was 16 more than ten percent of his body weight after defendants discontinued his Ensure. Id. at ¶¶ 8, 17 15, 16.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Lujan v. National Wildlife Federation
497 U.S. 871 (Supreme Court, 1990)
Crawford-El v. Britton
523 U.S. 574 (Supreme Court, 1998)
County of Sacramento v. Lewis
523 U.S. 833 (Supreme Court, 1998)
Barbara P. Hutchinson v. United States of America
838 F.2d 390 (Ninth Circuit, 1988)
Toguchi v. Soon Hwang Chung
391 F.3d 1051 (Ninth Circuit, 2004)
Earnest Woods, II v. Tom Carey
684 F.3d 934 (Ninth Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Auvil v. CBS "60 Minutes"
67 F.3d 816 (Ninth Circuit, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
(PC) Jones v. Bick, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pc-jones-v-bick-caed-2024.